Utilization of cognitive support in episodic free recall as a function of apolipoprotein E and vitamin B12 or folate among adults aged 75 years and older.

Apolipoprotein E (APOE), vitamin B12, and folate were examined in relation to free recall among 167 community-based older adults. Cognitive support at encoding and retrieval was also taken into account. Participants were classified as APOE e4 or non-epsilon4 allele carriers and as either low or normal vitamin B12 or folate status. A significant association was identified between low vitamin B12 and the epsilon4 genotype in respect to free recall, but only in circumstances of low cognitive support. This result remained after removing dementia cases that occurred up to 6 years after testing. A similar, but nonsignificant, trend was evident in relation to folate. The research is discussed with reference to vulnerability models and genetic influences on brain reserves.

[1]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[2]  J. M. Guralnik,et al.  The role of APOE-&egr;4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging , 2003 .

[3]  E. Cochran,et al.  Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer’s disease , 2003, Neurology.

[4]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[5]  I. Deary,et al.  The influence of the e4 allele of the apolipoprotein E gene on childhood IQ, nonverbal reasoning in old age, and lifetime cognitive change , 2003 .

[6]  P. Satz.  Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory. , 1993 .

[7]  A. Spiro,et al.  Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. , 1996, The American journal of clinical nutrition.

[8]  P. Lewinsohn,et al.  Stressful Life Events and Their Contexts , 1983 .

[9]  J. Lindeboom,et al.  Association between apolipoprotein E ε4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia , 1998 .

[10]  J. Lindeboom,et al.  Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. , 1998, Archives of neurology.

[11]  R. Kaplan,et al.  Cognitive recovery with vitamin B12 therapy , 1994, Neurology.

[12]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[13]  Y. Stern.  What is cognitive reserve? Theory and research application of the reserve concept , 2002, Journal of the International Neuropsychological Society.

[14]  H. Jacqmin-Gadda,et al.  Longitudinal analysis of the effect of apolipoprotein E ε4 and education on cognitive performance in elderly subjects: the PAQUID study , 2002, Journal of neurology, neurosurgery, and psychiatry.

[15]  H. Maxon,et al.  Semiautomated system for simultaneous assays of serum vitamin B12 and folic acid in serum evaluated. , 1982, Clinical chemistry.

[16]  J. Mortimer,et al.  Is APOE-ε4 a risk factor for cognitive impairment in normal aging? , 2000, Neurology.

[17]  J. Cummings,et al.  Alzheimer's disease , 1998, Neurology.

[18]  J. Bryan,et al.  B vitamins, cognition, and aging: a review. , 2001, The journals of gerontology. Series B, Psychological sciences and social sciences.

[19]  J. Francis,et al.  Time Dependency of Cognitive Recovery with Cobalamin Replacement: Report or a Pilot Study , 1992, Journal of the American Geriatrics Society.

[20]  L. Thal,et al.  Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. , 1999, Psychology and aging.

[21]  David Bunce,et al.  Age differences in vigilance as a function of health-related physical fitness and task demands , 2001, Neuropsychologia.

[22]  Tamara B. Harris,et al.  The Relationship of APOE Genotype to Cognitive Functioning in Older African‐American and Caucasian Community Residents , 2001, Journal of the American Geriatrics Society.

[23]  B. Winblad,et al.  The influence of serum vitamin B12 and folate status on cognitive functioning in very old age , 2001, Biological Psychology.

[24]  P. Rabbitt,et al.  Apolipoprotein E genotype does not predict decline in intelligence in healthy older adults , 2002, Neuroscience Letters.

[25]  L. Kuller,et al.  Estrogen use, APOE, and cognitive decline , 2000, Neurology.

[26]  D. Bunce.  The Locus of Age × Health-Related Physical Fitness Interactions in Serial Choice Responding as a Function of Task Complexity: Central Processing or Motor Function? , 2001, Experimental aging research.

[27]  B. Winblad,et al.  Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. , 1992, Neuroepidemiology.

[28]  R. Baumgartner,et al.  Serum Vitamin B12, C and Folate Concentrations in the New Mexico Elder Health Survey: Correlations with Cognitive and Affective Functions , 2000, Journal of the American College of Nutrition.

[29]  M. Mattson,et al.  Folic Acid Deficiency and Homocysteine Impair DNA Repair in Hippocampal Neurons and Sensitize Them to Amyloid Toxicity in Experimental Models of Alzheimer's Disease , 2002, The Journal of Neuroscience.

[30]  G. Schellenberg,et al.  Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E 4 status , 1999 .

[31]  B. Winblad,et al.  Vitamin B12 and folate in relation to the development of Alzheimer’s disease , 2001, Neurology.

[32]  David Bunce,et al.  Cognitive support at encoding attenuates age differences in recollective experience among adults of lower frontal lobe function. , 2003, Neuropsychology.

[33]  B. Winblad,et al.  Further evidence on the effects of vitamin B12 and folate levels on episodic memory functioning: a population-based study of healthy very old adults , 1999, Biological Psychiatry.

[34]  G. Small,et al.  Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[35]  K. Welsh-Bohmer,et al.  Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. , 1997, Neurology.

[36]  E. K. Eric Gunderson,et al.  Life Stress and Illness , 1974 .

[37]  B. Hyman,et al.  Apolipoprotein E and cognitive change in an elderly population , 1996, Annals of neurology.

[38]  W. Jagust,et al.  The Role of APOE ∊4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly Persons , 1999 .

[39]  Caroline Hayward,et al.  Ageing: Cognitive change and the APOE ɛ4 allele , 2002, Nature.

[40]  Yaakov Stern,et al.  Memory performance in healthy elderly without Alzheimer’s disease: effects of time and apolipoprotein-E , 2001, Neurobiology of Aging.

[41]  L. Bäckman,et al.  Three-year changes in cognitive performance as a function of apolipoprotein E genotype: evidence from very old adults without dementia. , 1998, Psychology and aging.

[42]  C. Judd,et al.  Statistical difficulties of detecting interactions and moderator effects. , 1993, Psychological bulletin.

[43]  S. Resnick,et al.  Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype , 2000, Neurology.

[44]  R. Katzman.,et al.  Education and the prevalence of dementia and Alzheimer's disease , 1993, Neurology.

[45]  F. Lalonde,et al.  Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women , 2001, Neurology.

[46]  Ian J. Deary,et al.  Cognitive change and the APOE epsilon 4 allele. , 2002 .

[47]  I. Skoog.  Detection of preclinical Alzheimer's disease. , 2000, The New England journal of medicine.

[48]  B. Winblad,et al.  Effects of serum vitamin B12 and folate status on episodic memory performance in very old age: a population-based study. , 1996, Psychology and aging.

[49]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[50]  B. Winblad,et al.  Clinical diagnosis of Alzheimer's disease and other dementias in a population survey. Agreement and causes of disagreement in applying Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, Criteria. , 1992, Archives of neurology.

[51]  E. L. Mortensen,et al.  A gender difference in the association between APOE genotype and age-related cognitive decline , 2001, Neurology.

[52]  M. Drake.  Diagnostic and Statistical Manual of Mental Disorders (3rd ed. rev.) , 1988 .

[53]  H. Christensen,et al.  Change in cognitive functioning associated with apoE genotype in a community sample of older adults. , 2002, Psychology and aging.